Company intelligence / Profile preview

StoCastic

Ownership: Private
Development stage: Commercial

Overview

StoCastic developed artificial intelligence solutions to provide evidence-based clinical decision support specifically tailored to emergency departments. Their technology aimed to improve patient outcomes and operational efficiency by supporting clinicians with real-time recommendations at the point of care. The company was acquired by Beckman Coulter Diagnostics in October 2022.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Beckman Coulter Diagnostics

Beyond the preview

Go deeper on StoCastic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on StoCastic.

Explore the full profile